Recent Updates
Recently added Catalysts

MOVIPREP

Phase 3

Bowel Preparation Prior to Endoscopic, Radiological and Other Examinations as Well as to Surgical Procedures Which Require Empty Bowel. | Small molecule | Gastrointestinal |Takeda Pharmaceutical Company Limited|Last Updated: May 15, 2014

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
RandomizedCONTROLLEDBiomarker
Total Trials1
Total Enrollment140
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT01732692Evaluation of the Efficacy, Safety and Tolerance of Experimental Morning-only MOVIPREP® Bowel Preparation in Comparison With Split-dose With Nocturnal Pause MOVIPREP® Bowel PreparationPHASE3 COMPLETED 140Nov 1, 2012Apr 1, 2013May 15, 20143 Kazakhstan, Russia
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Percentage of Participants With Successful Colon Cleansing
1 day (the day of colonoscopy)

Bowel cleansing was assessed by a blinded endoscopist through visual evaluation of 5 colon segments and scored using the Harefield Cleansing Scale (HCS): A = success, all segments clean/scored 4 or 3; B = success, ≥1 segment with liquid/semi-solid amounts of stool, fully removable, ≥1 segment scored 2; C = failure, ≥1 segment with semi-solid or solid amounts of stool, at least 1 segment scored 1; and D = failure, ≥ 1 segment with irremovable, heavy, hard stools, ≥ 1 segment scored 0. Segmental evaluation of colon cleansing scores is as follows: 4: Colon empty and clean, no remaining stool or liquid. 3: Presence of clear liquid in the gut which can be removed by suction. 2: Brown liquid or semisolid remaining amounts of stool, fully removable. 1: Semisolid amounts of stool, only partially removable, difficult to make colonoscopy; 0: Irremovable, heavy, hard stools, colonoscopy impossible. Success of cleansing was defined as Grades of bowel cleansing А and В.

Secondary Endpoints
Patient Satisfaction of Colonoscopy Preparation (VAS)
1 day (the day of colonoscopy)
Total Compliance Score
1 day (the day of colonoscopy)
Patient Compliance - Amount of Additional Clear Liquid Consumed
1 day (the day of colonoscopy)
Unlock Study Endpoints
Study Design & Arms
AllocationRANDOMIZED
MaskingSINGLE
ModelPARALLEL
PurposeTREATMENT
Treatment Arms
ArmTypeDescription
MOVIPREP (Morning-only dose)EXPERIMENTALMOVIPREP 250 ml solution every 15 minutes for up to one hour (4 doses in 1 hour=1 litre of solution), twice within same morning of colonoscopy.
MOVIPREP (Split-dose)OTHERMOVIPREP 250 ml solution every 15 minutes for up to one hour (4 doses in 1 hour=1 litre of solution), once the evening before colonoscopy and once the morning of colonoscopy.
Interventions
NameTypeDescription
MOVIPREPDRUGMOVIPREP solution
Unlock Study Design Details
Eligibility Criteria
Age Range18 Years — 85 Years
SexALL
Healthy VolunteersNo
Study Sites3

Inclusion Criteria: * male or female ≥18 years and ≤ 85 years * colonoscopy procedure indicated * willing to stay in the outpatient clinical site for colonoscopy and questionnaire completion * willing and able to undergo study-related procedures * informed consent signed by a patient for participat...

Countries:KazakhstanRussia
Unlock Eligibility Criteria